Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Biologics Contract Development Market Be Worth By 2029?
The size of the biologics contract development market has seen rapid expansion in the past few years. Rising from $7.75 billion in 2024, it is estimated to extend to $8.55 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. Factors contributing to growth during the historic period include the expansion of the biologics market, the increase in biopharmaceuticals, the intricacy of biologics, patent expirations, and cost efficiency.
The market size of biologics contract development is slated for a significant surge in the forthcoming years, with an estimated worth of $13.08 billion by 2029, expanding at a compound annual growth rate (CAGR) of 11.2%. This anticipated expansion during the forecast period is due in large part to elements such as data analytics and digitalization, risk management strategies, enhanced flexibility and scalability, a substantial increase in R&D investments, and advancements in precision medicine and personalized treatments. Major forecast period trends exploring regenerative medicine, risk management initiatives, global partnerships, advanced technology deployments and technology integration will also contribute to this growth.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8219&type=smp
What Market Forces Are Contributing To The Growth Of The Biologics Contract Development Market?
The escalating incidence of sustained illnesses is projected to drive the growth of the biologics contract development market. Sustained illnesses refer to health issues persisting for over a year, necessitating continuous medical care. The increasing number of long-term disease cases prompts the need for new drug creation, including biologics, thus fostering the biologics contract development market. For example, the Office for Health Improvement & Disparities in the UK reported in September 2024 that there were 3,940 deaths in excess due to chronic lower respiratory diseases in just the first half of 2023, signifying a 30% surge in comparison to projected rates. For the full year, this figure climbed to 5,363, representing an overall 22% increase. Consequently, the escalating instances of sustained diseases will fuel the expansion of the biologics contract development market.
Which Segments Define The Structure Of The Biologics Contract Development Market?
The biologics contract developmentmarket covered in this report is segmented –
1) By Source: Microbial; Mammalian; Others Sources
2) By Indication: Oncology; Immunological Disorders; Cardiovascular Disorders; Hematological Disorders; Others Indications
3) By Product Service: Cell Line Development; Process Development; Others Product Services
Subsegments:
1) By Microbial: Bacterial Sources; Yeast Sources; Fungal Sources
2) By Mammalian: Chinese Hamster Ovary (CHO) Cells; Human Embryonic Kidney (HEK) Cells; Hybridoma Cells
3) By Other Sources: Plant-Based Systems; Insect Cell Systems; Algal Sources
Which Long-Term Trends Will Play A Crucial Role In The Biologics Contract Development Market?
The biologics contract development market is witnessing a rise in the adoption of innovative technologies. To maintain their competitive edge, major firms in this sector are integrating cutting-edge technologies. An example of this is Lonza, a Swiss contract manufacturing and development solutions firm, which introduced the bYlok technology platform in January 2022. This platform facilitates the design and production of bispecific antibodies, resolving the light-heavy chain mispairing problem with more than 95% precision, high yields, and the ability to preserve a mAb-like format. Pharmaceutical and biotechnology companies can easily avail this technology through a straightforward research license.
Which Firms Are Making The Biggest Impact In The Biologics Contract Development Market?
Major companies operating in the biologics contract development market are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc, LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., AbbVie Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Meridian Life Science Inc., Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Sartorius AG, Syngene International Limited, Vibalogics GmbH, Yposkesi
Access The Complete Report Here:
Which Region Is Forecasted To Lead The Biologics Contract Development Market In The Coming Years?
North America was the largest region in the biologics contract development market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=8219&type=smp
Browse Through More Reports Similar to the Global Biologics Contract Development Market 2025, By The Business Research Company
Chemicals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report
Ethylene Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ethylene-global-market-report
Genetically Modified Crops Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model